The rise of Sildenafil initially sparked a surge for major pharmaceutical companies, however recent changes present a uncertain scenario for investors. Off-patent versions are eroding profits, and ongoing litigation https://murrayqmut144753.mybloglicious.com/61092429/sildenafil-and-big-pharma-a-risky-investment